University Hospitals Brain Health & Memory Center is now treating patients with KISUNLA鈩� (donanemab), a Food and Drug Administration-approved medication for the treatment of Alzheimer鈥檚 disease. UH is the only health system in Northeast Ohio currently offering these infusion treatments.
People with Alzheimer鈥檚 exhibit a loss of motor control along with cognitive decline, and one of the earliest signs of this decay can be spotted in involuntary eye movements known as saccades. These quick twitches of the eyes in Alzheimer鈥檚 patients are often slower, less accurate, or delayed compared to those in healthy individuals.
Rutgers Institute for Health researcher lead a study examining the impact of educational attainment on cognition later in life.
A doctoral student in speech-language pathology at Universit茅 de Montr茅al is testing the use of audiovisual content to support communication in people with dementia.
More than 11 million Americans are tasked with the responsibility of taking care of someone with cognitive decline.
A new study from the University of Delaware will look at Alzheimer's disease (AD) and examine how changes in arterial stiffness and brain tissue in midlife adults could contribute to cognitive decline. The study aims to pinpoint early risk factors and explore preventive interventions.
Cedars-Sinai has published a summary highlighting its research advances for November 2024.
MSU researchers receive $4M NIH grant to study dementia risks
Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer鈥檚 genesis and progression. The proteins were gathered from cerebrospinal fluid and are a good proxy for activity in the brain. Several of them may be potential targets for therapies.
Irvine, Calif., Nov. 14, 2024 鈥� Researchers led by the University of California, Irvine are the first to reveal how two neural circuits located in the brain鈥檚 retrosplenial cortex are directly linked to spatial navigation and memory storage. This discovery could lead to more precise medical treatments for Alzheimer鈥檚 disease and other cognitive disorders by allowing them to target pathway-specific neural circuits.
.jpg&width=400&height=400)
In a groundbreaking study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases鈥攖wo rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain and spinal cord. After years of investigating the diseases鈥� underlying mechanisms, the research team has identified an existing FDA-approved drug that could significantly improve quality of life for affected patients and their families.
The University of Kentucky聽Sanders-Brown Center on Aging聽Director Linda Van Eldik, Ph.D., hopes to shed light on how specific brain cells may contribute to the progression of Alzheimer鈥檚 disease, paving the way for potential new therapeutic approaches.Van Eldik recently received a three-year, $300,000 award from the聽BrightFocus Foundation聽to support her research project, 鈥淩elationship between astrocyte p38 MAPK, neuroinflammation, and Alzheimer pathology.
Experts on healthy aging from Cedars-Sinai鈥檚 growing Center for Translational Geroscience and Geriatrics Program will present their latest research and clinical advances at The Gerontological Society of America鈥檚 (GSA) 2024 Annual Scientific Meeting in Seattle, Nov. 13-16.
The Acoustical Society of America will host two virtual press conferences Monday, Nov. 18. ASA鈥檚 187th meeting will be held online, and reporters are invited to join technical sessions Nov. 19-21. Media are invited to join the virtual press conferences for presentations on dinosaur acoustics, using camp stove waste for new outdoor power sources, predicting Alzheimer鈥檚 with in-ear microphones, and more.
Older people who are sleepy during the day or lack enthusiasm for activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia, according to a study published in the November 6, 2024, online issue of Neurology庐, the medical journal of the American Academy of Neurology.
A review article entitled 鈥淧revalence of Antibiotic Resistance in Older Adults and Alzheimer鈥檚 Disease Patients: A Systematic Review and Meta-Analysis,鈥� is now published in the Journal Alzheimer鈥檚 Disease Reports.
University of Wisconsin鈥揗adison researchers are warning that artificial intelligence tools gaining popularity in the fields of genetics and medicine can lead to flawed conclusions about the connection between genes and physical characteristics, including risk factors for diseases like diabetes.The faulty predictions are linked to researchers鈥� use of AI to assist genome-wide association studies.
Electronics and Telecommunications Research Institute (ETRI) is conducting research on the development of an AI technology that can evaluate and predict brain function degeneration and brain-related diseases such as mild cognitive impairment, dementia, etc., by analyzing the speech utterances of the elderly that can be obtained through their daily conversations.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
